INTRODUCTION
Most cell types in multicellular organisms require an unequal distribution of proteins, lipids, and mRNA for their function (1) . This phenomenon is referred to as cell polarity. During development, the differential segregation of cell fate determinants (anterior-posterior polarity) forms the basis for asymmetric cell division and ultimately the generation of body axes and cell diversity. In differentiated cells, partitioning of the cell membrane into functionally discrete domains enables cells to execute their specialized functions within an organism. Epithelia are a classic example of polarized cells and display apicobasal polarity. Whereas the apical side faces the exterior or lumen, the basal domain is directed toward the interior extracellular matrix and interstitial space in tissues and organs. The lateral cell surface allows neighboring epithelial cells to adhere and to communicate through cell-cell junctions. However, epithelial cells can also lose their polarity and acquire a migratory, mesenchymal character. Although this process is vital for embryonic development and tissue repair, it is also a key event in cancer metastasis. Elucidating the basic mechanisms underlying cell polarity thus has broad implications for our understanding of developmental and oncogenic processes.
Although polarized cells vary substantially in their morphology and function, polarity depends in all cell types on the Par (partitioningdefective) protein complex that is conserved across the animal phyla (2) . The Par complex constitutes the major molecular machinery for creating the mutually exclusive signaling networks that cover large areas of the cell cortex in polarized cells. In epithelia, the Par complex is a key polarity regulator at the apical surface and engages in intricate signaling networks with the Crumbs complex and cell adhesion proteins, such as E-cadherin and nectins [Shotgun (Shg) and Echinoid (Ed), respectively, in Drosophila], to form and maintain cell junctions (1, 3) .
The Par complex comprises atypical protein kinase C (aPKC) and two scaffolding proteins, Par3 [Bazooka (Baz) in Drosophila] and Par6 (Fig. 1A) . Although a single set of genes encodes the Par complex in invertebrates, this gene family has expanded to two genes encoding Par3 and Par3L, two genes encoding aPKC isoforms (PKC/ and PKC), and three genes encoding Par6, Par6, and Par6 in vertebrates (4) (5) (6) . Par6 and aPKC heterodimerize with high affinity through their N-terminal PB1 (Phox and Bem1) domains (Fig. 1A) (7, 8) . In addition, Par6 contains a Crib (Cdc42/Rac-interactive binding) motif that is N-terminal to a PDZ protein-protein interaction domain. Par3 contains an N-terminal PB1-like homo-oligomerization domain (9) , three central PDZ domains, and a C-terminal region with an aPKC phosphorylation site (10) (11) (12) (13) . Whether Par3 interacts directly with Par6 has remained controversial. The Par3 PDZ1 domain has been described to heterodimerize with the Par6 Crib-PDZ domain (Fig. 1A) (14) (15) (16) . However, these reports disagree on whether the Par6 Crib motif is essential for the Par3:Par6 interaction. Moreover, the in vivo relevance of this interaction has been debated (16) , and last, the Par3:Par6 interaction has been reported to be indirect, requiring aPKC as a linker molecule (7, 10) . Given these conflicting observations, we sought to investigate the mechanism of Par3:Par6 association on a structural and functional level.
PDZ domain interactions are a recurring theme in polarity and cellcell adhesion protein networks. PDZ domains fold into a six-stranded antiparallel -sheet capped by two -helices (17) and predominantly bind with low affinity [typically in the micromolar range (18, 19) ] to short (4 to 15 amino acids), disordered sequences at the C termini of target proteins, so-called PDZ-binding motifs (PBMs). This interaction results in an augmentation of the PDZ -sheet by an antiparallel -strand formed by the PBM. The four C-terminal residues constitute the specificity-determining core PBM (20) that can be categorized into three classes depending on the amino acid at the −2 position relative to the C terminus: X-[S/T]-X-φ-COO − (class I), X-φ-X-φ-COO − (class II), and X-[D/E]-X-φ-COO − (class III), with X being any amino acid and φ being a hydrophobic residue (21) . In addition, PDZ domains can recognize internal peptide sequences (22) or homo-or heterodimerize in some cases (14) (15) (16) .
Here, we uncovered the molecular basis of the Par3:Par6 interaction. We identified a previously unrecognized, highly conserved PBM in Par6 that was important for Par6 localization in vivo and essential for Par3:Par6 interaction in vitro. We found that both the Par3 PDZ1 and PDZ3 domains, but not the PDZ2 domain, associated through canonical PDZ:PBM interactions with the Par6 PBM and showed that one Par3 protein could recruit two Par6 molecules simultaneously. In cells, we found that the Par6 PBM was critical for Par3-mediated membrane recruitment of Par6 in cultured Drosophila Schneider 2R (S2R) cells and played a role in Par6 localization to the cell cortex in fly embryonic epidermal cells. In summary, our results provide important structural and functional details on the role of Par3 and Par6 in organizing polarity complexes.
RESULTS

Par6 contains a PBM that associates with the PDZ1 domain in Par3
To elucidate the molecular details of the Par3:Par6 interaction, we performed nuclear magnetic resonance (NMR) binding studies. This method is a powerful tool to study biomolecular interactions (23, 24) because the measured chemical shifts of atomic nuclei (that is, the peak positions in NMR spectra) are highly sensitive to changes in the local chemical environment. In a standard experiment, an unlabeled binding partner is titrated against an isotope-labeled, NMR-visible protein, resulting in concentration-dependent changes of the chemical shifts for the residues contacting the ligand [chemical shift perturbation (CSP)] that can be used to obtain dissociation constants (K d 's) ( fig. S1 , A to C). Together with chemical shift assignments, CSP studies enable the mapping of the ligand-binding surface on a protein structure with close to atomic resolution.
The Par3 PDZ1 heterodimerizes with the Par6 PDZ domain (14-16). However, this interaction has been debated (7, 10) . To investigate the mechanism of the Par3:Par6 interaction, we first recorded . Surprisingly, we observed that this PDZ domain was largely unfolded in isolation ( fig. S2A ). The domain architectures of the Par complex proteins are highly conserved in metazoans, suggesting that Par3 and Par6 interact in a similar manner (2) . We therefore investigated next whether the Drosophila melanogaster or Caenorhabditis elegans Par3 PDZ1 domains interact with the respective Par6 PDZ or Crib-PDZ domains. Although both the Drosophila and C. elegans Par3 PDZ1 domains were folded in isolation, we observed only few changes in the NMR spectra of the fig. S2 , F and G). We thus conclude that the Par3 PDZ domains do not associate directly with the Par6 PDZ domain.
In searching for an alternative binding mechanism, we revisited the Par6 protein sequence and identified a previously unrecognized class II (φ-X-φ-COO − ) PBM at its C terminus (Fig. 1B) . This motif is highly conserved in metazoans (Fig. 1B) except in nematodes (fig. S3 ), and we therefore focused our further efforts on the dPar3 and dPar6 proteins. To assess whether the identified Par6 PBM could interact with the Par3 PDZ domains, we performed NMR CSP experiments. Class II PBM:
Peptide position: (25) (26) (27) (28) (29) (66) (67) (68) . Conserved hydrophobic (φ) residues are in dark pink for the 0 and −2 positions and in light pink for the −3 position, whereas polar residues at the −1 position are in blue. Organism abbreviations are expanded in fig. S3 . PBMs used in this study are underlined. (C) Overlay of a representative region of the 1 Upon addition of an unlabeled peptide containing the eight C-terminal residues of dPar6, we observed large peak shifts (more than one peak width) and line broad ening for numerous residues in the 15 N-labeled dPar3 PDZ1 domain (Fig. 1C) , effects that would be expected for two proteins that specifically interact with each other. Thus, the dPar3 PDZ1 domain can directly interact with the dPar6 PBM in vitro. In support of this notion, epithelial cell polarity also critically depends on interactions of the Par3 PDZ domains with cell adhesion proteins through PBMs that are similar to the Par6 PBM (Fig. 1, B and D) (25) (26) (27) (28) (29) .
The Par6 PBM is important for interaction with Par3 in vitro and in cultured cells
To investigate the importance of the Par6 PBM for binding to Par3, we performed in vitro glutathione S-transferase (GST) pulldown experiments using a recombinant GST-tagged dPar3 fragment containing all three PDZ domains and Sumo-tagged dPar6 variants ( Fig. 2A) . The Par3 PDZ1-3 domains efficiently pulled down wild-type Par6 (Fig. 2B, lane 10 GST alone did not pull down any of the Par6 constructs in control experiments (Fig. 2B, lanes 9, 11, 13 , and 15). These pulldown experiments thus confirm our NMR experiments and show a direct interaction of the Par6 PBM with the Par3 PDZ domains in vitro.
To explore whether the Par6 PBM is important for Par3 interaction in cells, we transiently transfected Drosophila S2R cells with wild-type green fluorescent protein (GFP)-tagged Par6 or deletion constructs ( Fig. 2A ) in the absence (Fig. 2 , C to F) or presence of red fluorescent protein (RFP)-tagged Par3 (Fig. 2 , G to J). All Par6 variants were cytosolic in the absence of Par3 (Fig. 2, C to F) . However, in the presence of Par3, wild-type Par6 showed a strong colocalization with Par3 at the cell cortex (Fig. 2G) . A Par6 mutant lacking the PDZ domain (PDZ) was still recruited to the plasma membrane in the presence of Par3 (Fig. 2H) with only a small fraction remaining cytosolic. By contrast, Par3-mediated membrane targeting was reduced for the Par6 mutant that lacked the PBM (PBM; Fig. 2I and PDZPBM mutants. These findings suggest that the PDZ domain may have an additional function in Par6 localization when aPKC is present. In line with our NMR binding studies and in vitro assays, these cellular results show that the PBM of Par6 plays an important role in the interaction with Par3 and in Par3-mediated localization of Par6 to the cell cortex.
The PBM is functionally redundant with the PDZ domain in Par6 localization in vivo
To explore the in vivo relevance of our findings, we generated transgenic flies expressing GFP-tagged Par6 under a constitutive promoter (30) and analyzed the embryos at stage 11 ( Fig. 3 , A to D). As expected, we observed that wild-type GFP-Par6 accumulated predominately at the cell-cell contacts of epidermal cells and colocalized with Par3 and aPKC ( Fig. 3 , A and E). Whereas deletion of the Par6 PBM had no significant effect on Par6 localization (Fig. 3 , B and E), deletion of the PDZ domain resulted in a mild but consistent mislocalization of Par6 (Fig. 3 , C and E). By contrast, deletion of both the PDZ domain and the PBM caused a strong mislocalization of this Par6 mutant to the cytosol (Fig. 3 , D and E). All GFP-Par6 variants were expressed at similar amounts in fly embryos ( fig. S5A ). Thus, both the PDZ domain and the PBM contribute to the correct localization of Par6 in vivo, with deletion of both domains resulting in Par6 mislocalization. However, this effect may reflect an indirect association between Par3 and Par6 through aPKC as suggested previously (7, 10) and/or Par6 recruitment by other epithelial cell polarity regulators such as Crumbs or Stardust that bind to the Par6 PDZ domain (22, (31) (32) (33) (34) (35) .
Of these other polarity regulators, Stardust is expressed at earlier stages and thus is already present at stage 6 in fly embryos, whereas Crumbs is only expressed at later stages (36, 37) . We found that localization of the various Par6 constructs in stage 6-7 fly embryos (when gastrulation occurs) was similar to their localization in stage 11 embryos (fig. S5, B and E). Notably, the PDZPBM mutant was mislocalized in both stage 6-7 and stage 11 embryos. These findings demonstrate that Par6 recruitment to the cell cortex in vivo critically depends on both the PDZ domain and the PBM and suggest that these domains may be functionally redundant for Par6 localization in vivo.
In par6-null embryos (par6
226
), which normally die at late embryonic stages (38) 
The dPar3 PDZ1 domain forms a canonical PDZ:PBM complex with Par6
To gain structural insight into the Par3:Par6 complex, we crystallized a dPar3:dPar6 fusion construct comprising the Par3 PDZ1 domain and the C-terminal PBM octapeptide of Par6 (VKDGVLHL; the core PBM is underlined) and solved the x-ray structure of the PDZ1:PBM complex (table S1). Both the Par3 PDZ1 domain and the Par6 core PBM were well defined, with the PDZ1 domain adopting the typical PDZ fold and the core PBM forming the canonical antiparallel -strand with the PDZ1 2-strand ( Fig. 4A and fig. S7A ). The C-terminal carboxylate group was involved in an extensive hydrogen bond network with the backbone of the PDZ1 1-2 loop (Fig. 4A ). The hydrophobic residues at the 0 and −2 positions of the PBM were deeply buried in a hydrophobic pocket formed by the carboxylate-binding loop (Leu Fig. 4A and fig. S7B ). Overall, our structure was highly similar to other PDZ:PBM complexes such as the PDZ3 domain of INADL (inactivation-no-after-potential D like protein) in complex with a phage display-derived class II PBM peptide ( (40, 41) . Outside the core PBM, we observed less well-defined electron density for the Par6 peptide and three residues of the Gly-Ser-linker ( fig. S8, A and B) , indicating an additional antiparallel -strand formed by the last amino The Par3 PDZ1 and PDZ3 domains both recognize the Par6 PBM We noticed that the residues in the PDZ1 domain contacting the 0 and −2 PBM positions are well conserved in all three Par3 PDZ domains ( fig. S9 ). We therefore also tested the binding specificities of the Par3 PDZ2 and PDZ3 domains toward the Par6 PBM. To this end, we performed NMR binding studies with the individual dPar3 PDZ2 and PDZ3 domains and the dPar6 PBM peptide. In contrast to the PDZ1 domain, we observed virtually no CSPs for the Par3 PDZ2 domain upon addition of the Par6 PBM ( fig. S10A ). The Par3 PDZ2 domain thus has binding specificities that are distinct from the Par3 PDZ1 domain.
The PDZ3 domain contains a long, disordered insertion in the 2-3 loop that is unique to dPar3 ( fig. S9 ). Because this extension severely compromised spectral quality, we used a PDZ3 domain with a truncated 2-3 loop (PDZ3 2-3loop) for our NMR studies ( fig. S9) . As for the PDZ1 domain, addition of the Par6 PBM induced numerous, large CSPs in the 15 N-labeled PDZ3 2-3loop (Fig. 4C ). This finding demonstrates that the truncated PDZ3 domain is functional and interacts readily with the dPar6 PBM. To map the observed CSPs onto the surface of the PDZ3 domain, we obtained chemical shift assignments for the PDZ3 domain and generated a homology model of the Par3 PDZ3 domain. In this model, the PDZ3 domain binds the Par6 PBM in a canonical manner mainly involving the carboxylate-binding loop, the 2 strand, and the 2 helix (Fig. 4D) .
To obtain quantitative insights into the Par3 PDZ interactions with the Par6 PBM, we determined K d 's by NMR line shape fitting for the chemical shift titrations of the dPar3 PDZ1 and PDZ3 domains with the Par6 PBMs. Because the PDZ2 domain did not exhibit CSPs upon addition of the Par6 PBM, we did not fit these data. We found that the Par6 PBM bound to the PDZ1 domain with a moderate affinity of 216 ± 4 M and to the PDZ3 domain with a higher affinity of 54 ± 1 M for the PDZ3 domain [figs. S11 (A to C) and S12 (A to C) and table S2]. Next, we quantitatively addressed the importance of the three C-terminal positions in the Par6 PBM for PDZ1 binding (figs. S8E and S13). We found that mutation of the C-terminal position (L 0 A) weakened the affinity of the PDZ1 domain for the Par6 PBM by ~18-fold (table S2 and by ~11-fold, respectively (table S2 and fig. S13, E and F) . These results confirm that these mutations in the core PBM compromise binding to the Par3 PDZ1 domain and that these residues are thus important determinants for the interaction with the Par3 PDZ1 domain.
Overall, K d 's of up to a few hundreds of micromolars have been observed for physiologically relevant PDZ interactions (18, 19) . Together with our analyses of cultured S2R cells (Fig. 2 and fig. S4 ) and fly embryos (Fig. 3 and figs. S5 and S6) , our NMR analyses show that the interaction of the Par6 PBM plays a role in Par3 PDZ binding in vitro and is physiologically relevant in vivo. N-labeled dPar3 PDZ1-3 module that contains all three PDZ domains (PDZ1-3 2-3loop) and examined its Par6 binding capability. The NMR spectra of the Par3 PDZ1-3 module and the individual PDZ domains superimposed well (Fig. 5, A to C) , and resonance assignments of the individual domains could be transferred to the PDZ1-3 module. This finding demonstrates that the individual PDZ domains in Par3 are structurally largely independent. Addition of unlabeled Par6 PBM to the PDZ1-3 construct resulted in CSPs comparable to the isolated PDZ domains [ Fig. 5 (D to F) compared to Figs. 1C and 4C and fig. S10A ]. This finding shows that the Par3 PDZ domains act as functionally independent entities within the PDZ1-3 module and that one Par3 protein can simultaneously interact with two Par6 proteins through its PDZ1 and PDZ3 domains in vitro (Fig. 5G) . Par3 thus has the potential to engage in weak, multivalent interactions with Par6 and may thereby promote the assembly of largescale clusters of Par complexes at the cell membrane in vivo.
Par3 can interact with two Par6 proteins simultaneously in vitro
The Par6 PBM can compete with the PBM of E-cadherin for Par3 binding Cell adhesion proteins, such as cadherins and nectins, also interact with Par3 and contain conserved class II PBMs that are similar to the Par6 PBM (Fig. 1B and  fig. S7C fig. S14 (A and B) , fig. S12 (C and D) ]. The dPar3 PDZ domains thus have greater affinities for the PBM of Shg than for the Par6 PBM (albeit only by a factor of ~2 for the PDZ1 domain).
To evaluate whether the PBM of Par6 and Shg compete for binding to the Par3 PDZ1 or PDZ3 domains, we performed a set of NMR experiments on the 15 N-labeled Shg PBM. First, we recorded 1 H, 15 Ncorrelation spectra of the peptide in the absence or presence of unlabeled dPar3 PDZ1 or PDZ3 domain. In both cases, this resulted in PDZ:Shg complex formation as indicated by the observed CSPs (Fig. 6,  C and D) . Subsequently, we added Par6 PBM to the PDZ:Shg complex in a stepwise manner and found that Shg peptide was released from both PDZ domains as indicated by chemical shift changes that reverted toward the unbound Shg peptide (Fig. 6, C and D) . This finding demonstrates that the Par6 PBM can compete with Shg for Par3 PDZ binding. The relatively high stoichiometric amounts of Par6 PBM required to outcompete the Shg peptide from the PDZ3 domain reflect the large difference in binding affinities (table S2) . Ultimately, the question of direct competition between the Par6 PBM and other PBM-containing ligands for Par3 binding in vivo would require determining the specific subcellular concentrations of Par3, Par6, and other binding partners; the binding affinities within the fully assembled Par complex; and the exact chronological order of binding events in cells. These are certainly highly interesting, although challenging topics for future studies.
The PDZ:PBM interaction is conserved in human Par3 and Par6 proteins
To explore whether the PDZ:PBM interactions that mediate Par3:Par6 association in Drosophila are conserved in the human proteins, we cotransfected human embryonic kidney (HEK) 293T cells with Flagtagged hPar3 and Myc-tagged wild-type or truncated hPar6. Fulllength Par6 readily coprecipitated with Par3, which was abrogated by deletion of the Par6 PBM (PBM) or deletion of both the Par6 PDZ domain and the PBM (PDZPBM; Fig. 7A ). By contrast, Par3 coimmunoprecipitated comparable amounts of Par6 PDZ and wild-type Par6. Consistent with our in vitro and in vivo data for the Drosophila Par3:Par6 interaction, the results of our coimmunoprecipitation experiments demonstrate that the Par6 PBM is also important for the interaction of the human proteins.
To examine whether the mode of interaction and the specificities of the individual PDZ domains toward the Par6 PBM are conserved among human and dPar3, we performed NMR binding studies. Because the hPar3 PDZ1 domain was unfolded in isolation ( fig. S2A) , we fused the eight C-terminal residues of hPar6 to the C terminus of the hPar3 PDZ1 domain separated by a 15-amino acid Gly-Ser-linker. The PDZ1:PBM fusion had a well-dispersed 1 H, 15 N-correlation spectrum demonstrating that the Par6 PBM induced the folding of the PDZ1 domain and hence interacted with the Par3 PDZ1 domain (Fig. 7B) . Addition of unlabeled Par6 PBM peptide to the 15 N-labeled hPar3 PDZ2 domain resulted in a few, although partially substantial, CSPs (Fig. 7C and fig. S10C ) indicating that the hPar3 PDZ2 domain binds to the Par6 PBM. By contrast, the PDZ3 domain displayed numerous, large CSPs in the presence of Par6 (Fig. 7D) . Mapping of the observed CSPs on the structures of the hPar3 PDZ2 and PDZ3 domains showed that both domains could engage the Par6 PBM through canonical PDZ:PBM interactions ( fig. S10, C and D) . Together, these results demonstrate that the Par3 PDZ:Par6 PBM interactions and the functions of the Par3 PDZ domains are largely conserved in the human and Drosophila proteins.
DISCUSSION
Here, we have identified a previously unrecognized PBM in Par6 that mediates canonical PDZ:PBM interactions with the PDZ1 and PDZ3 domains of Par3. This interaction mode is conserved among the human and Drosophila Par3 and Par6 proteins. We demonstrate that the PBM, but not the PDZ domain, of Par6 is essential for interaction with Par3 in vitro. Yet, the PBM seems to be redundant with the PDZ domain in Par6 localization in fly epithelia because the individual deletions only mildly reduce cortical localization in vivo, and deletion of both the PBM and the PDZ domain is required for almost complete mislocalization of Par6.
Overall, we did not find evidence of heterodimerization of the human, Drosophila, or C. elegans Par3 PDZ domains with the respective Par6 PDZ domain by NMR ( fig. S2 ), in GST pulldown (Fig. 2B) or coimmunoprecipitation experiments (Fig. 7A) , or in recruitment assays in S2R cells (Fig. 2, D and H) . Our results thus provide important insights into Par complex assembly and contrast with previous reports that suggest that Par3 and Par6 associate through PDZ:PDZ interaction (14, 16, 29) . In support of our findings, Par3 associated in epithelial cells with various cell adhesion proteins having class II PBMs that are similar to the Par6 PBM (Fig. 1B) , and we showed that the dPar3 PDZ1 and PDZ3 domains also interacted with the major cell adhesion protein E-cadherin (Shg; Fig. 6, A and B) . These interactions are crucial for the establishment and maintenance of cell junctions and epithelial cell polarity (3, (25) (26) (27) (28) (29) . Notably, as in the case of Par6, these adhesion protein interactions are conserved among human and Drosophila Par3. In summary, this sup ports the notion that class II PBMs constitute a general binding motif for the Par3 PDZ1 and PDZ3 domains to recruit polarity and cell adhesion proteins for the establishment and maintenance of cell polarity. Nematodes may constitute an exception because not only do their Par6 but also their cadherin (Hammerhead-1; HMR-1) proteins lack a detectable, C-terminal PBM (fig. S3) . Future studies will thus be required to elucidate the mechanism of Par3 PDZ interactions and their role in cell polarity in nematodes.
Tandem arrangement of PDZ domains allows scaffolding proteins to assemble different components of a signaling cascade through multivalent interactions (42) based on the independent folding and function of interaction domains embedded in proteins (43) . We found that the isolated Par3 PDZ1 and PDZ3 domains could independently interact with the Par6 PBM [Figs. 5 (D and F) and 7 (B and D)] and thus may be redundant. These functional redundancies allow each Par3 molecule to simultaneously recruit two Par6 proteins in vitro (Fig. 5G) . Together with Par6:aPKC heterodimerization and Par3 homo-oligomerization, this provides a basis for the role of Par3 in enforcing the spatial segregation and the assembly of large-scale, self-organizing Par complex networks at the cell cortex in vivo. The mode of Par3:Par6 interaction has remained controversial, which reflects the challenges of delineating the specific functions of proteins and their individual domains and motifs in cell polarity. Functional coupling, redundant interactions, differences in organism strains, cell types, and protein constructs and finally the existence of paralogs hamper in vivo analyses of polarity proteins (10, 44) . Moreover, the composition of polarity complexes is dynamic and may depend on the cell type or developmental context (45) . Last, different populations of polarity proteins could coexist within a single cell (46) . These issues are obstacles for functional analyses because phenotypes may be obscured in mutational studies. Detailed structural analyses are thus essential to unambiguously determine the molecular basis of polarity complex formation. Moreover, the requirement for a free C terminus for PBM function suggests that C-terminal tagging for fluorescence microscopy or immunoblotting likely abrogates not only Par3:Par6 association but possibly also other Par6 PBM interactions that have yet to be identified.
The presence of at least one PDZ domain or a PBM in almost all polarity and cell adhesion proteins emphasizes the importance of 
Myc-hPar6α
Flag-hPar3 A detailed characterization of the functional specificities and redundancies of PDZ domains, as presented here, contributes to deciphering their contribution to polarity protein localization and function. Ultimately, elucidating the binding specificities of individual domains will help to predict PDZ domain function and provide a better understanding of the interaction networks underlying the establishment, maintenance, and loss of cell polarity and hence critical developmental and carcinogenic processes.
MATERIALS AND METHODS
Reagents and constructs
Par3 and Par6 constructs were cloned from C. elegans cDNA, S2R cell cDNA, or a synthetic gene fragment (Life Technologies) containing the Par3 PDZ domains (D. melanogaster). pK-myc-Par3b (hPar3) and pK-myc-Par6C (hPar6) vectors were purchased from Addgene (plasmid #19388 and #15474). For NMR studies, gene fragments amplified by polymerase chain reaction were cloned into the following vectors: pETZ2.1a (His 6 -Z domain-TEV) for C. elegans. Par3 and Par6 constructs; pET-M41 (His 6 -MBP-TEV) for dPar3 PDZ domains, dPar3 PDZ1:dPar6 PBM fusion, dPar6 PDZ, and Crib-PDZ constructs; pET-M30 (His 6 -GST-TEV) for the dPar3 PDZ1-3 2-3loop, hPar3 PDZ domains, and the hPar3:Par6 PBM fusion constructs; and pRTDuet-GB1 (His 6 -GB1-TEV) for all Par6 and Shg PBM peptides. For GST pulldown experiments, a gene fragment containing the three dPar3 PDZ domains was cloned into a pETM30-HA (His 6 -GST-TEV-HA) vector, whereas full-length and truncated dPar6 constructs were cloned into a pET-M11-Sumo (His 6 -Sumo-TEV) vector. For S2R cell transfection, dPar3 and dPar6 were cloned into pENTR vectors. Site-directed mutagenesis was carried out with the Par6 pENTR vector as the DNA template using the following primers: Par6 PDZ, 5′-GTGCCGGAAACGCATGGTGGAGGTGGAGGTCCGGC-CAATCAGCGC-3′ and Par6 PBM, 5′-ACGATAATGGCCAGC-GATTAAATCGATGGAGTGCTGCATTTG-3′.
Par3 and wild-type and mutant Par6 variants were subsequently sub cloned into pUGW and pURW vectors from the Drosophila Genomics Resource Center (30), respectively. For coimmunoprecipitation studies, the Myc-tag in the pK-myc-Par3b vector was replaced by a Flag-tag using QuikChange mutagenesis. All deletions in the hPar6 gene were generated by QuikChange mutagenesis using the pK-myc-Par6C vector as the DNA template. For a complete list of constructs, see table S3.
Expression and purification of recombinant proteins
Recombinant proteins were expressed in Escherichia coli BL21-CodonPlus (DE3)-RIL cells (Stratagene) and purified by Ni affinity and size-exclusion chromatography. To facilitate peptide production, we fused the Par6 and Shg PBMs at their N termini to the immunoglobulin-binding domain B1 of streptococcal protein G (GB1) domain followed by a TEV protease cleavage site. For NMR binding experiments, nonspecific binding of GB1 alone was tested. For NMR studies, unlabeled His 6 -GB1-Par6 and His 6 -GB1-Shg peptides or dPar3 PDZ domains were expressed in LB medium, and 15 N-or 13 C, 15 N-labeled His 6 -GB1-Shg, Par3 PDZ or Par6 Crib-PDZ, and PDZ domains were expressed in M9 minimal medium with 15 C-glucose as sole sources of nitrogen and carbon. All NMR constructs were buffer-exchanged into NMR buffer [20 mM Na phosphate (pH 6.5 or 7.5), 150 mM NaCl, 1 mM dithiothreitol (DTT), and 0.03% NaN 3 ] for triple-resonance and CSP experiments.
Proteins for pulldown experiments were expressed as His 6 -GST-HA (human influenza hemagglutinin)-tagged dPar3 and His 6 -Sumo-tagged dPar6 proteins in E. coli BL21-CodonPlus (DE3)-RIL cells (Stratagene) in LB medium and purified by Ni affinity chromatography. Subsequently, buffer was exchanged by dialysis to 50 mM Na phosphate (pH 7.5), 150 mM NaCl, 1 mM DTT, and 10% glycerol for Par6 proteins or to 20 mM Na phosphate (pH 6.5), 150 mM NaCl, 1 mM DTT, and 10% glycerol for Par3 proteins.
Pulldown assays dPar3 proteins containing an N-terminal His 6 -GST-HA-tag were incubated with glutathione beads (Macherey-Nagel) at 1 M concentration together with 65 M dPar6 proteins that contained an N-terminal His 6 -Sumo-tag for 1 hour at 4°C in pulldown buffer [50 mM Na phosphate (pH 7.5), 150 mM NaCl, 10% glycerol, and 2 mM DTT]. The beads were washed four times with pulldown buffer and specifically bound proteins eluted with pulldown buffer supplemented with 25 mM reduced glutathione. Eluted proteins were precipitated with 10% (w/v) trichloroacetic acid (Sigma) on ice followed by centrifugation. Protein pellets were resuspended in SDS loading buffer, resolved by SDS-polyacrylamide gel electrophoresis (PAGE), and detected by Coomassie staining.
S2R cell culture
Immunostainings of transfected S2R cells were carried out as previously described (12) . Briefly, S2R cells were transfected using FUGENE (Promega) with Ubi::GFP-Par6 variants alone or with Ubi::RFP-Baz. Cells were fixed with paraformaldehyde and imaged with a Zeiss LSM 710 Meta confocal microscope. RNAi-mediated knockdown of aPKC was performed as described (47) . Briefly, a ~300-base pair doublestranded RNA (dsRNA) fragment was taken up by the cells and processed to several small interfering RNAs (siRNAs). One dsRNA thus results in several siRNAs and thereby reduces the probability of offtargets. The efficiency of dsRNA-mediated gene knockdown of aPKC was confirmed by a Western blot of S2R cell lysates using aPKC (1:1000; Santa Cruz Biotechnology, sc-216) and mouse actin (1:1000; Santa Cruz Biotechnology, sc-47778) antibodies. The following oligonucleotides were used to amplify a fragment of aPKC mRNA for in vitro transcription into dsRNA: aPKC-dsRNA-F, 5′-ACTTCGC-GTTCTCCGC-3′ and aPKC-dsRNA-R, 5′-TTGCTAGCTGGGTA-AAATATTTTGA-3′.
HEK293T cell culture and coimmunoprecipitation HEK293T cells were transfected with N-terminally Flag-tagged hPar3 in a pKFlag and N-terminally Myc-tagged hPar6 in a pKMyc expression vector using Lipofectamine (Invitrogen); grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Invitrogen), 2 mM l-glutamine (Invitrogen), penicillin (Invitrogen), and streptomycin (Invitrogen); and harvested 3 days after transfection. Cells were lysed in NET buffer [50 mM tris-HCl (pH 8.0), 150 mM NaCl, 0.1% (w/v) Triton X-100, and 1 mM EDTA] supplemented with proteinase inhibitor cocktail (Roche). The supernatants were incubated with Flag M2 antibody (2 g/mg of cell lysate) and subsequently with GammaBind Plus Sepharose (GE Healthcare) for 1 hour each at 4°C. The beads were washed three times with NET buffer and once with Triton-free NET buffer. Immunoprecipitated proteins were eluted with SDS loading buffer, separated by SDS-PAGE, and immunoblotted using mouse Flag M2 (1:1000; Sigma) as primary and horseradish peroxidase (HRP)-coupled mouse immunoglobulin G (1:10,000) as secondary antibody (Thermo Fisher Scientific) or mouse Myc-HRP (1:5000; Life Technologies) antibody. Western blots were imaged by chemiluminescence. For quantitative analysis, signal intensities were determined for three independent experiments with ImageJ (Fiji) (48) , and the immunoprecipitated proteins normalized to the total lysate (input). Two-tailed t tests were performed on the amalgamated data using the ttest2 routine in MATLAB v2017b (MathWorks) to estimate P values.
Fly stocks and genetics
Fly stocks were cultured on standard cornmeal agar food and maintained at 25°C. Transgenic flies of Ubi::GFP-Par6 variants were established using the PhiC31 integrase system with attP40 in a wild-type background (49) . Fly embryo lysates were applied to SDS-PAGE and immunoblotted using rabbit GFP (1:500; Santa Cruz Biotechnology, sc-8334) and mouse actin (1:1000; Santa Cruz Biotechnology, sc-47778) antibodies to ensure uniform expression of the Par6 mutants. Western blots were imaged by chemiluminescence. To evaluate the function of GFP-Par6 and GFP-Par6 PDZ, PBM, and PDZPBM mutants in a Par6-null background, the transgenes were backcrossed into a homozygous par6 226 mutant background (38) . However, only the wild-type and PBM transgenes can rescue the embryonic lethality of par6 226 mutant flies and be kept as stable stocks.
Immunohistochemistry
Drosophila stage 6-7 or stage 11 embryos were fixed in 4% formaldehyde phosphate buffer (pH 7.4), as previously described (30) . The primary antibodies used for indirect immunofluorescence were as follows: mouse aPKC (PKC; 1:500; Santa Cruz Biotechnology, sc-17781), rabbit GFP (1:500; Santa Cruz Biotechnology, sc-8334), and guinea pig Baz (1:500). Secondary antibodies conjugated with Alexa 488, Alexa 568, and Alexa 647 (Life Technologies) were used at 1:400. Images of the epidermis were taken from stage 11 embryos on a Zeiss LSM 710 Meta confocal microscope or at stage 6-7 on a Leica SP8 confocal microscope. For colocalization analysis, we analyzed the images of four embryos for each Par6 variant (Fig. 3E and fig. S6C ). Pearson's correlation coefficients and SD were estimated after automatic thresholding using the Costes' approach as implemented in the JACoP v2.0 plugin of ImageJ (Fiji) (48, 50, 51) . Two-tailed t tests were performed using the ttest2 routine in MATLAB v2017b (MathWorks) to estimate P values.
NMR spectroscopy
CSP studies were performed with 75-to 100-M samples of 15 N-labeled protein in NMR buffer {20 mM Na phosphate [pH 6.5 (individual PDZ domains or Shg PBM) or 7.5], 150 mM NaCl, 1 mM DTT, and 0.03% NaN 3 } by recording 1 H, 15 N-heteronuclear single-quantum coherence (HSQC) experiments on a 600-MHz Bruker Avance III spectrometer at 20°C for the Drosophila and C. elegans Par3 and Par6 PDZ domains and at 30°C for the human proteins. For CSP studies with the dPar3 PDZ1-3 2-3loop module, we recorded 1 H, 15 N-transverse relaxation optimized spectroscopy (TROSY) experiments at 600 MHz and 30°C in 20 mM Na phosphate (pH 7.5), 150 mM NaCl, and 1 mM DTT. Backbone resonance assignment for the dPar3 PDZ domains was performed at 20° and 25°C for the hPar3 PDZ2 and PDZ3 domains by recording three-dimensional (3D) HNCACB, HNCOCACB, CCONH, and HNH-NOESY spectra at 600 or 800 MHz. NMR data were processed using the nmrPipe/nmrDraw software suite (52) and analyzed using XEASY (53) and Sparky (54 , where  is the difference in chemical shift at a ninefold stoichiometric excess of Par6 PBM to the respective reference in the absence of ligand. For binding site mapping, a homology model of the dPar3 PDZ3 domain was generated using HHPred (55) , and Protein Data Bank (PDB) entries 2KOM and 2KOH were used for binding site mapping for the hPar3 PDZ2 (56) and PDZ3 (41) 
X-ray crystallography
The dPar3 PDZ1:dPar6 fusion construct was crystallized in 0.1 M bis-tris (pH 6.5) and 2 M (NH 4 ) 2 SO 4 . Diffraction data were collected at 100 K using a wavelength of 1 Å and a PILATUS 6M-F detector at the beamline PXII of the Swiss Light Source (Paul Scherrer Institute). Data were processed using XDS (59) , and molecular replacement was performed using Phaser (60) . The structure was finalized by iterative manual modeling with Coot (61) and refinement with Phenix (62) . Each asymmetric unit contains two protein chains with virtually identical conformations (backbone root mean squared displacement of 0.031 Å for the PDZ1 domain and the core PBM). All figures displaying protein structures were generated using PyMOL (www.pymol.org).
Sequence alignment
Multiple sequence alignments were performed with MUSCLE (63) and displayed with ClustalX (64). The position-weighted matrix for the Par6 PBM was created with WebLogo 3.4 (65) using all Par6 PBMs displayed in fig. S3 . The overall height of the stack indicates the sequence conservation at that position, whereas the height of a symbol within the stack indicates the relative frequency of each amino acid at that position.
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